CrownBio’s Integrated Oncology Platform Helps Advance Apogenix’s Promising HERA-GITRL Immunotherapy for NSCLC and Head and Neck Cancer

World News: . []

SANTA CLARA Calif Sept 13 2017 GLOBE NEWSWIRE -- a wholly-owned subsidiary of Crown Bioscience International TWSEticker 6554 and a global drug discovery and development services company providing translational platforms to advance onco logy, i...

More news and information about Crown Bioscience

Published By:

Globe Newswire: 15:04 GMT Wednesday 13th September 2017

Published: .

Search for other references to "crownbio" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Ground Floor Offices, Little Keep Gate, Barrack Road, Dorchester, Dorset DT1 1AH
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us
 

Advertising on SPi News: Information For Advertisers